Galectin Therapeutics (GALT) Interest Coverage Ratio Growth (5y) (2016 - 2026)
Galectin Therapeutics (GALT) Interest Coverage Ratio Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.25% |
| Dec 31, 2025 | 65.52% |
| Sep 30, 2025 | 61.41% |
| Jun 30, 2025 | 61.27% |
| Mar 31, 2025 | 51.16% |
| Dec 31, 2024 | 15.03% |
| Sep 30, 2024 | 45.83% |
| Jun 30, 2024 | 42.68% |
| Mar 31, 2024 | 38.89% |
| Dec 31, 2023 | 37.27% |
| Sep 30, 2023 | 18.65% |
| Jun 30, 2023 | 20.72% |
| Mar 31, 2023 | 14.68% |
| Dec 31, 2022 | -188.57% |
| Dec 31, 2021 | 249.45% |
| Dec 31, 2020 | -228.71% |
| Dec 31, 2019 | -212.10% |
| Dec 31, 2018 | -124.67% |
| Dec 31, 2017 | 40.62% |
| Dec 31, 2016 | 43.97% |